share_log

We Think That There Are More Issues For Raffles Medical Group (SGX:BSL) Than Just Sluggish Earnings

We Think That There Are More Issues For Raffles Medical Group (SGX:BSL) Than Just Sluggish Earnings

我们认为莱佛士医疗集团(新加坡交易所:BSL)面临的问题不仅仅是业绩疲软。
Simply Wall St ·  08/04 20:30

The market wasn't impressed with the soft earnings from Raffles Medical Group Ltd (SGX:BSL) recently. We did some further digging and think they have a few more reasons to be concerned beyond the statutory profit.

这次新加坡交易所莱佛士医疗集团有限公司(SGX:BSL)软性收益未能打动市场。我们进一步挖掘认为,除了净利润外,他们还有其他一些值得担忧的原因。

big
SGX:BSL Earnings and Revenue History August 5th 2024
SGX:BSL 收益和营业收入历史 2024年8月5日

How Do Unusual Items Influence Profit?

非常规项目如何影响利润?

To properly understand Raffles Medical Group's profit results, we need to consider the S$7.6m gain attributed to unusual items. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).

要适当理解莱佛士医疗集团的收益结果,我们需要考虑新币760万的非常项目增益。我们无法否认更高的收益通常会让我们感到乐观,但我们更希望收益能够持续。当我们对成千上万的上市公司进行数据分析时,我们发现某年因非常项目的提升带来的收益提升往往不会在下一年重复出现。总之,这正是会计术语所意味的。假设这些非常项目在当前年度不再出现,那么我们预计收益将会较低(在业务增长缺失的情况下)。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

这可能会让您想知道分析师对未来盈利能力的预测。幸运的是,您可以单击此处查看基于其估计的未来盈利能力的互动图表。

Our Take On Raffles Medical Group's Profit Performance

我们对莱佛士医疗集团的收益表现的看法

Arguably, Raffles Medical Group's statutory earnings have been distorted by unusual items boosting profit. Therefore, it seems possible to us that Raffles Medical Group's true underlying earnings power is actually less than its statutory profit. In further bad news, its earnings per share decreased in the last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. If you want to do dive deeper into Raffles Medical Group, you'd also look into what risks it is currently facing. For example, we've discovered 1 warning sign that you should run your eye over to get a better picture of Raffles Medical Group.

可以说,莱佛士医疗集团的法定收益已被非常项目扭曲,从而提高了收益。因此,我们认为莱佛士医疗集团的真正核心收益能力可能低于其法定收益。更糟糕的是,其每股收益在过去一年中下降了。当然,就分析其收益而言,我们刚刚只是挖掘表层,人们还可以考虑利润率、预测增长、投资回报率等其他因素。如果您想更深入地了解莱佛士医疗集团,您还应该调查当前面临的风险。例如,我们发现了1个警示信号,您应该详细考虑,以更好地了解莱佛士医疗集团。

This note has only looked at a single factor that sheds light on the nature of Raffles Medical Group's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.

这份笔记仅研究了揭示莱佛士医疗集团收益性质的单一因素。但是,如果您能够将思维集中在细枝末节上,就会发现更多内容。一些人认为,高股本回报率是优质业务的良好标志。因此,您可能希望查看这个免费的高股本回报率公司收藏,或者这个拥有高内部所有权股票清单的清单。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发